Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
AstraZeneca
Moodys
McKinsey
Dow

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ANGIOTENSIN II ACETATE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for angiotensin ii acetate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00239096 Prevention of Decompensation in Liver Cirrhosis Unknown status Else Poulsen Mindelegat Phase 4 2005-09-01 The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic.
NCT00239096 Prevention of Decompensation in Liver Cirrhosis Unknown status Lundbeck Foundation Phase 4 2005-09-01 The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic.
NCT00239096 Prevention of Decompensation in Liver Cirrhosis Unknown status University of Southern Denmark Phase 4 2005-09-01 The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic.
NCT00239096 Prevention of Decompensation in Liver Cirrhosis Unknown status Odense University Hospital Phase 4 2005-09-01 The purpose of this study is to determine whether losartan, an angiotensin II blocker prevents the sodium retention in patients with liver cirrhosis and by that reduces the fluid retention. Moreover is the purpose to asses whether losartan is antifibrotic.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for angiotensin ii acetate

Condition Name

Condition Name for angiotensin ii acetate
Intervention Trials
Hyperphosphatemia 1
Haemodialyzed Patients 1
Cough 1
Ascites 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for angiotensin ii acetate
Intervention Trials
Cough 1
Ascites 1
Vascular Diseases 1
Hyperphosphatemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for angiotensin ii acetate

Trials by Country

Trials by Country for angiotensin ii acetate
Location Trials
United States 3
Denmark 1
Turkey 1
Romania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for angiotensin ii acetate
Location Trials
North Carolina 1
New York 1
Colorado 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for angiotensin ii acetate

Clinical Trial Phase

Clinical Trial Phase for angiotensin ii acetate
Clinical Trial Phase Trials
Phase 4 3
Phase 2 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for angiotensin ii acetate
Clinical Trial Phase Trials
Unknown status 2
Completed 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for angiotensin ii acetate

Sponsor Name

Sponsor Name for angiotensin ii acetate
Sponsor Trials
Gulhane School of Medicine 2
National Heart, Lung, and Blood Institute (NHLBI) 1
Else Poulsen Mindelegat 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for angiotensin ii acetate
Sponsor Trials
Other 9
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Mallinckrodt
Express Scripts
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.